Literature DB >> 6827670

Urothelial carcinoma after cyclophosphamide therapy.

S M Moinuddin, D W Upton.   

Abstract

We report a case of transitional cell carcinoma of the bladder after cyclophosphamide therapy for chronic lymphocytic leukemia. Urologic evaluation and histologic confirmation occurred only after low grade tumor cells were identified in multiple urine samples. Malignant cells can be distinguished from drug effect in urinary specimens from patients treated with cyclophosphamide and all such cases should include regular cytologic evaluations.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6827670     DOI: 10.1016/s0022-5347(17)51964-3

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  2 in total

1.  Bladder carcinoma following cyclophosphamide therapy. A case report.

Authors:  H Kiesswetter; N Baloch; J Flamm
Journal:  Int Urol Nephrol       Date:  1985       Impact factor: 2.370

Review 2.  Comparative activity of ifosfamide and cyclophosphamide.

Authors:  W Brade; S Seeber; K Herdrich
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.